RESULTS	The relative risk of progression of disease or death was 0.57 ( 95 % CI , 0.43 to 0.75 ) with cisplatin and 0.51 ( 95 % CI , 0.38 to 0.67 ) with cisplatin-based combination chemotherapy compared with hydroxyurea .\